Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia

The presence of KMT2A/AFF1 rearrangement in B-lymphoblastic leukemia (B-ALL) is an independent poor prognostic factor and has been associated with higher rate of treatment failure and higher risk of linage switch under therapy. Blinatumomab has shown promising therapeutic results in refractory or re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Case Rep Hematol
Main Authors: He, Rui R., Nayer, Zacharia, Hogan, Matthew, Cuevo, Raymund S., Woodward, Kimberly, Heyer, David, Curtis, Christine A., Peterson, Jess F.
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2019
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925828/
https://ncbi.nlm.nih.gov/pubmed/31885955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7394619
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker